Skip to main content
Adult Acute Lymphoblastic Leukemia ALL

Treatment of Adult Acute Lymphoblastic Leukemia

Cancer Connect - Treatment of Adult Acute Lymphoblastic Leukemia

Image placeholder title

STAMP inhibitor Scemblix (ssciminib, ABL001) for CML

Scemblix superior responses compared to Bosulif for treatment of chronic myeloid leukemia - active in T315I mutations

Image placeholder title

Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.

Leukemia Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Leukemia Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.